Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...

ONDCP leads and coordinates the nation’s drug policy so that it improves the health and lives of the American people. ONDCP is responsible for the development and implementation of the National Drug ...

DSN spoke with John Colaizzi, group vice president and head of enterprise pharmacy practice for Walgreens, to discuss the nationwide expansion of its PharmStart program. Accetta, senior vice president ...